Recurrent scarring papulovesicular lesions on sun-exposed skin in a 22-year-old man - 28/02/18
Doi : 10.1016/j.jaad.2017.08.005
Melissa A. Levoska, BS a, b, Jeffrey I. Cohen, MD c, Irini Manoli, MD, PhD d, Chyi-Chia Richard Lee, MD, PhD e, Steven S.T. Ching, MD f, Jessica Shand, MD, MHS g, Deborah Tamura, RN, MS a, Kenneth H. Kraemer, MD a, John J. DiGiovanna, MD a, ⁎ 
a Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
e Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
b Medical Research Scholars Program, National Institutes of Health, Bethesda, Maryland
c Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
d Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland
f Flaum Eye Institute, University of Rochester, Rochester, New York
g Division of Pediatric Hematology-Oncology and Wilmot Cancer Center, University of Rochester, Rochester, New York
∗Correspondence to: John J. DiGiovanna, MD, Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, 37 Convent Dr, Rm. 4002, Bethesda, MD 20892-4262.Laboratory of Cancer Biology and GeneticsNational Cancer InstituteNIH, 37 Convent Dr, Rm. 4002BethesdaMD20892-4262
Abstract |
Key teaching points |
• | Typical HV is a self-limited EBV-associated disorder of children and adolescents characterized by recurrent outbreaks of scarring papulovesicular lesions. The criterion standard diagnostic test is biopsy of an active lesion showing reticular degeneration and demonstrating EBV RNA (EBER positivity) in lymphocytes. |
• | Avoiding sun exposure by using photoprotection can reduce outbreaks. |
• | Patients typically have high levels of circulating EBV DNA, which is best detected from whole blood rather than from serum or plasma. |
• | In patients with persistent skin disease activity, following EBV DNA levels in the blood can help assess for the development of aggressive systemic disease. |
• | Severe HV disease associated with chronic active EBV may progress to lymphoproliferative disorders or lymphoma with increased mortality. |
Key words : EBV-associated lymphoproliferative disorders, Epstein-Barr virus, hydroa vacciniforme, photodermatosis, photosensitivity
Plan
| Supported by the Intramural Research Programs of the Center for Cancer Research, National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Human Genome Research Institute, National Institutes of Health (NIH). Support for Ms. Levoska was made possible through the NIH Medical Research Scholars Program, a public-private partnership supported jointly by the NIH and generous contributions to the Foundation for the NIH from the Doris Duke Charitable Foundation, the American Association for Dental Research, the Colgate-Palmolive Company, Genentech, and other private donors. For a complete list, visit the foundation website at www.fnih.org. |
|
| Conflicts of interest: None disclosed. |
|
| Reprints are not available from the authors. |
© 2017
Publié par Elsevier Masson SAS.
Vol 78 - N° 3
P. 637-642 - mars 2018 Retour au numéro
Article précédent
- The ethics of medical marijuana in dermatology
- Walter Liszewski, Benjamin K. Stoff, Ronda S. Farah
- Crowdsourcing dermatology: DataDerm, big data analytics, and machine learning technology
- Andrew J. Park, Justin M. Ko, Robert A. Swerlick
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?